Optimal use of G-CSF administration after hematopoietic SCT
Meghana V. Trivedi(University of Houston), Edward D. Ball(Sheba Medical Center), Sam Martinez(University of California, San Diego), Katherine Medley(University of California, San Diego), Sue Corringham(University of California, San Diego)
Cited by 69
Related Papers
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|595
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
|Journal of Clinical Oncology|2013|439
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
|Cancer Research|2018|221